TScan Therapeutics
engineering donor cells to eliminate residual leukemia cells preventing patient relapse and risk of death scan a sok | TScan Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
23 of 43
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights